what's the difference between tirzepatide and semaglutide dulaglutide vs. for weight loss—what's difference? 🤔Both have become very popular, but knowing which one is right for you matters. Semaglutide boosts gut health reduces inflammation Discover Tirzepatide and Semaglutide: Which

Yes, Semaglutide has been shown to improve other health markers such as reducing the risk of cardiovascular disease and improving glycemic control in people with type 2 diabetes

Not intended for human consumption, therapeutic use, veterinary application, or medical treatment

Many people in our community are looking for real solutions that work for the long term

Eligibility requirements for the GLP-1 Bridge Program include: Age 18 or older Enrollment in a Medicare Part D or Medicare Advantage Prescription Drug (MA-PD) plan One of the following BMI and health condition combinations: BMI 35 (regardless of other health conditions) BMI 30 with at least one of the following: heart failure with preserved ejection fraction (HFpEF), hypertension, or chronic kidney disease (CKD) BMI 27 with a history of pre-diabetes, myocardial infarction, stroke, or peripheral artery disease (PAD) The program covers the following GLP-1 receptor agonists: Foundayo (orforglipron) tablet, all dose strengths and formulations Wegovy (semaglutide) injections and tablets, all dose strengths and formulations Zepbound (tirzepatide) injections, only when prescribed as the KwikPen (single-dose vials and other single-dose pen formats are excluded) All prescriptions require prior authorization through Humana, which oversees clinical review to ensure adherence to the program's strict medical-necessity guidelines